We are excited to announce our new PODCAST series to highlight the upcoming NASPAG ACRM 2022.
The first podcast is live now! The ACRM 2022 Program Chair, Dr. Nancy Sokkary, talks about plans for our upcoming conference, what’s new and what’s the same!
Lots to look forward to and a fantastic opportunity to reunite in one of our favorite conference cities!
2022 NASPAG Board of Directors Nominations
(click for full letter)
January 10 - deadline to submit request to serve within the Nominating Committee
January 14 - All Nomination Due
Dr. Sanfilippo Development Fund & Education Series
Dates: December 9, January 13, February 10
Dr. Joseph Sanfilippo has a phenomenal history with NASPAG as a founding member, President, Executive Director and Editor-in-Chief of the Journal of Pediatric and Adolescent Gynecology.
As part of his ongoing support of NASPAG, Dr. Sanfilippo has graciously offered to donate matched funds up to $10,000 from now until the ACRM in April 2022.
We ask you to please consider contributing to this special fundraising campaign and support NASPAG!
NASPAG's missions and goals have evolved under Dr. Sanfilippo’s leadership. In recognition of this and as part of the fundraising campaign, we will be hosting a three-part virtual education series with topics relevant to the tenets of the mission and goals: clinical care, education, research, advocacy, and equity.
Session 2: January 13, 2022, 8:00 PM ET
Title: Fertility Preservation: Optimizing Outcomes
Speaker: Leslie C. Appiah, M.D.
Associate Professor of Obstetrics and Gynecology
Chief, Division of Academic Specialists in Obstetrics and Gynecology
Director, Fertility Preservation and Reproductive Late Effects Program
University of Colorado
Fee: The program is complementary, but we encourage donations.
Session 1: Recorded on December 9, 2021
Title: Adolescent Endometriosis: A 30 Year Journey on the Road to a Cure
Speaker: Marc R. Laufer, M.D.
Chief of Gynecology; Boston Children's Hospital;
Center for Infertility & Reproductive Surgery, Brigham & Women's Hospital;
Professor of Obstetrics, Gynecology & Reproductive Biology, Harvard Medical School
Fee: The program is complementary, but we encourage donations.
Talking points - COVID-19 Vaccine and Reproductive Health:
With ongoing COVID-19 surges, the need for vaccine uptake among adolescent and young adults is critical to safety and decreasing transmission. Although there is no preferred vaccine formulation, the Pfizer-BioNtech vaccine is the sole formulation that received full FDA approval. Twelve to seventeen-year olds are currently only eligible to receive the Pfizer-BioNtech vaccine. The FDA has also recently approved the Pfizer-BioNtech vaccine for those 5-11 years of age, and it is anticipated that other countries will approve the same in the coming weeks around the world.
NASPAG'S Response to Texas Senate Bill 8
NASPAG’s mission is to advocate for the reproductive well-being of children and adolescents and the provision of unrestricted, unbiased, and evidence-based practice of Pediatric and Adolescent Gynecology. The Texas Senate Bill 8 undermines the ability of Pediatric and Adolescent health care providers to align with NASPAG’s mission. This bill impacts critical reproductive health care, which undoubtedly will disproportionately impact those with poorest resources and access to care. This is one of the most restrictive abortions bans in the US, making abortion illegal with no exceptions for rape, sexual abuse, incest, or fetal anomaly diagnosis.
